Arctic Fox Biomedical enables the control of fat cells for aesthetic and therapeutic applications.
Arctic Fox Biomedical has raised $50.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2022.
Arctic Fox Biomedical's investors include MedCap Advisors.
Arctic Fox Biomedical is headquartered in Cambridge, United States.
Arctic Fox Biomedical enables the control of fat cells for aesthetic and therapeutic applications.
Arctic Fox Biomedical is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Arctic Fox Biomedical — Funding & Investors." VCBacked, November 4, 2022, https://www.vcbacked.co/company/arctic-fox-biomedical. Accessed November 13, 2026.
VCBacked. (2022). Arctic Fox Biomedical — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/arctic-fox-biomedical
{{cite web |title=Arctic Fox Biomedical — Funding & Investors |url=https://www.vcbacked.co/company/arctic-fox-biomedical |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Arctic Fox Biomedical? Request a listing update